55.07MMarket Cap
LossP/E TTM
CNTX Balance Sheet
You can check out the annual or quarterly balance sheets of Context Therapeutics Inc here to evaluate the financial health, analyze fundamentals, and calculate key ratios for liquidity, leverage, and return on equity.
FAQs
Which balance sheet metrics matter most when analyzing CNTX stock?
Important metrics include cash and short-term investments, total assets, current assets, total liabilities, current liabilities, long-term debt, shareholders' equity, retained earnings, inventory, receivables, working capital, current ratio, quick ratio, debt-to-equity ratio, and return on equity. Investors usually review these together rather than relying on one number.
What is the difference between assets, liabilities, and shareholders' equity?
Assets are resources the company owns or controls, such as cash, receivables, inventory, investments, and property. Liabilities are obligations the company owes, such as accounts payable, debt, leases, and taxes. Shareholders' equity is the residual value after liabilities are subtracted from assets.
What is the difference between current and non-current items?
Current assets and current liabilities are generally expected to be converted, used, paid, or settled within one year or one operating cycle. Non-current assets and non-current liabilities are longer-term items, such as property, long-term investments, deferred tax assets, long-term debt, and lease obligations.
How Much Cash Does Context Therapeutics Inc Have?
In its most recent quarterly, Context Therapeutics Inc had 54.53M in cash and cash equivalents.
What Are Context Therapeutics Inc's Total Assets?
As of the latest reported quarter, Context Therapeutics Inc's total assets were 68.49M, consisting of 68.35M in current assets and 140.07K in non-current assets.
How Much Shareholders' Equity Does Context Therapeutics Inc Have?
Context Therapeutics Inc reported 60.47M in total shareholders' equity as of the latest reported quarter.